🔎 Trials Near Me

Home › Neuroendocrine Tumors › Michigan › Detroit

Neuroendocrine Tumors clinical trials in Detroit, MI

7 studies for Neuroendocrine Tumors are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

RecruitingPhase 2/3
  • Henry Ford Cancer- Detroit, Detroit
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06943755

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

RecruitingPhase 3
  • Henry Ford Cancer - Detroit, Detroit
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07087054

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Children's Hospital of Michigan, Detroit
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RecruitingPhase 1/2
  • Crinetics Study Site, Detroit
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07129252

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

RecruitingPhase 1/2
  • Barbara Ann Karmanos Cancer Institute, Detroit
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618

F-Tryptophan PET/CT in Human Cancers

RecruitingPhase 1
  • Karmanos Cancer Institute, Detroit
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT05556473

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Recruiting
  • Karmanos Cancer Institute, Detroit
Ages 18 and older · All sexes · Updated Aug 26, 2025 · NCT06908629

Neuroendocrine Tumors trials in other cities

Other studies in Detroit

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.